Pluripotent Stem Cell Isolation Using Connexin 43 Marker
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for effective methods to isolate homogeneous populations of pluripotent stem cells from neural crest tissue, such as the adult periodontal ligament, and to condition these cells for specific regenerative medicine applications, as existing technologies face challenges in achieving pure isolation and efficient differentiation.
Innovation Solution
The use of connexin 43 as a selection marker to isolate pluripotent stem cells from neural crest-derived tissue, followed by methods to differentiate these cells into specific lineages such as neural or retinal progenitor cells using growth factors and signaling pathway antagonists.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional methods are used to isolate stem cells from neural crest tissue, then cell population can be obtained, but the population is heterogeneous and not pure
Solution Approach 1:
The patent uses fluorescent markers (color changes) to identify and sort connexin 43-positive cells through flow cytometry. Cells are stained with fluorescently-labeled antibodies against connexin 43, allowing precise identification and separation of the desired stem cell population from heterogeneous tissue samples, thereby achieving high purity isolation.
Solution Approach 2:
The patent replaces mechanical/enzymatic tissue dissociation methods with a biomarker-based selection system. Instead of relying on physical separation or enzymatic digestion to isolate stem cells, the invention uses connexin 43 as a specific molecular marker to identify and sort the desired cells, achieving higher precision without increasing mechanical complexity.
2Adaptability or versatility
If pluripotent stem cells are isolated from adult tissues, then ethical issues are avoided, but the cells have limited differentiation potential compared to embryonic stem cells
Solution Approach 1:
The patent extracts and utilizes connexin 43, a specific molecular marker, from adult neural crest-derived tissues to isolate pluripotent stem cells. This extraction approach enables the identification and isolation of cells with embryonic-like differentiation potential from adult sources, combining the ethical advantages of adult cells with the versatility of pluripotent cells.
Solution Approach 2:
The patent changes the parameter of cell source from embryonic to adult tissues while maintaining pluripotency through connexin 43 selection. By selecting for connexin 43-positive cells from adult periodontal ligament or other neural crest-derived tissues, the method achieves pluripotent differentiation capacity without the ethical and immunological issues associated with embryonic stem cells.
3Manufacturing precision
If stem cells are isolated without specific markers, then isolation process is simple, but the resulting population is mixed and not homogeneous
Solution Approach 1:
The patent introduces connexin 43 as an intermediary marker to bridge the gap between simple isolation procedures and homogeneous cell population achievement. Connexin 43 serves as a specific mediator that enables flow cytometry-based sorting, allowing operators to easily select and isolate pure stem cell populations without complex multi-step procedures.
Data Source
AI summary
The present invention relates to methods of isolating a substantially homogeneous population of pluripotent stem cells from adult neural crest tissue (e.g., periodontal ligament) as well as pharmaceutical compositions comprising such isolated pluripotent stem cells. Methods of inducing the isolated pluripotent stem cells into specific cell lineages, such as neurogenic and retinogenic lineages, are also described. The isolated pluripotent stem cells find use in various regenerative medicine applications and the treatment of degenerative diseases.